Clinical Trial Update: Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

View source ↗

Summary

Clinical trial update on adjuvant treatment for stage II-III rectal cancer using concurrent radiotherapy with CAPOX or capecitabine alone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Rectal Neoplasms | Status: UNKNOWN